Sources: Alphabet's Isomorphic Labs in Talks to Raise About $5 Billion

Nov. 5 — Bloomberg, citing people familiar with the matter, reported that Isomorphic Labs, Alphabet's AI drug discovery company, is in talks to raise about $5 billion in new funding, in a round that would value it at about $50 billion. The sources said the funding is not yet finalized and details may change. Isomorphic Labs was spun out of Google DeepMind in 2021 and carries out drug discovery based on the AlphaFold protein structure prediction model. In May this year, it completed a $2.1 billion funding round led by Thrive Capital, with Alphabet and others participating.